Literature DB >> 3045124

Insulin action rapidly decreases multifunctional protein kinase activity in rat adipose tissue.

S Ramakrishna1, W B Benjamin.   

Abstract

ATP-citrate lyase in vivo contains three phosphorylation sites on two tryptic peptides (peptides A and B). These phosphorylation sites are under hormonal control. Multifunctional protein kinase (MFPK) from rat liver phosphorylates peptide B on serine and threonine residues whereas cAMP-dependent protein kinase phosphorylates peptide A on a serine residue (Ramakrishna, S., and Benjamin, W. B. (1985) J. Biol. Chem. 260, 12280-12286). We now report that rat adipose tissue MFPK also phosphorylates serine and threonine residues of peptide B of ATP-citrate lyase. When the activity of MFPK was assayed using partially purified (by chromatography on phosphocellulose) cytosol fractions from insulin-treated adipose tissue, it was found that MFPK activity was decreased by over 55%. This decrease in MFPK activity occurs at physiological concentrations of insulin (EC50 = 1 x 10(-10) M). Its onset is rapid and almost maximal at 5 min after the addition of insulin. Even when new protein synthesis is inhibited by cycloheximide, extracts from insulin-treated fat pads have less MFPK activity compared to the control. The insulin effect is maintained after further chromatography on a gel filtration column suggesting that the decrease in MFPK activity is not due to a low molecular weight inhibitor. The insulin-induced decrease in MFPK activity is due to a decrease in Vmax whereas the affinity of this enzyme toward ATP-citrate lyase or ATP is unchanged.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045124

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Insulin signal transduction through protein kinase cascades.

Authors:  J Avruch
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

2.  An insulin-sensitive cytosolic protein kinase accounts for the regulation of ATP citrate-lyase phosphorylation.

Authors:  K T Yu; W B Benjamin; S Ramakrishna; N Khalaf; M P Czech
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

Review 3.  Alois Alzheimer revisited: differences in origin of the disease carrying his name.

Authors:  K Maurer; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-23       Impact factor: 3.575

4.  Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B.

Authors:  G I Welsh; C G Proud
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

Review 5.  Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?

Authors:  S Patel; B Doble; J R Woodgett
Journal:  Biochem Soc Trans       Date:  2004-11       Impact factor: 5.407

Review 6.  The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.

Authors:  Katrin Morgen; Lutz Frölich
Journal:  J Neural Transm (Vienna)       Date:  2015-02-12       Impact factor: 3.575

7.  Identification of multifunctional ATP-citrate lyase kinase as the alpha-isoform of glycogen synthase kinase-3.

Authors:  K Hughes; S Ramakrishna; W B Benjamin; J R Woodgett
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

8.  Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling.

Authors:  C Sutherland; I A Leighton; P Cohen
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

9.  The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells.

Authors:  Y Saito; J R Vandenheede; P Cohen
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

10.  ATP citrate-lyase and glycogen synthase kinase-3 beta in 3T3-L1 cells during differentiation into adipocytes.

Authors:  W B Benjamin; S N Pentyala; J R Woodgett; Y Hod; D Marshak
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.